Adverse Prognostic Significance of Activation-Induced Cytidine Deaminase in Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP.

Cancer Rep (Hoboken) · 2026 · PMC13124646 · PMID 42050342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Rituximab addition to CHOP showed a protective effect with an adjusted HR of 0.62 (95% CI: 0.26–1.49, p = 0.288), though this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.